Scalpel Weekly News

Week of: July 31, 2017

IN THE NEWS


Antiviral Drug for Chronic Hepatitis C Patients Approved

On July 18, 2017, the FDA approved Vosevi to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis. Vosevi is a fixed-dose, combination tablet containing two previously approved drugs – sofosbuvir and velpatasvir – and a new drug, voxilaprevir. Vosevi is the first treatment approved for patients who have been previously treated with the direct-acting antiviral drug sofosbuvir or other drugs for HCV that inhibit a protein called NS5A. Click title to continue reading...


 
MEDICAL ALERTS


First Neonatal MRI Device for Brain and Head Scans

On July 20, 2017, the FDA cleared the first magnetic resonance imaging (MRI) device specifically for neonatal brain and head imaging in neonatal intensive care units (NICU). Click title to continue reading...



Treatment to Reduce Risk of Breast Cancer Return Approved

On July 17, 2017, the FDA approved Nerlynx (neratinib) for the extended adjuvant treatment of early-stage, HER2-positive breast cancer. For patients with this type of cancer, Nerlynx is the first extended adjuvant therapy, a form of therapy that is taken after an initial treatment to further lower the risk of the cancer coming back. Click title to continue reading...



More Than 100 Million Americans Have Diabetes or Prediabetes

On July 18, 2017, the CDC published a new report that found that as of 2015, 30.3 million Americans – 9.4 percent of the U.S. population – had diabetes. Another 84.1 million had prediabetes, a condition that if not treated often leads to type 2 diabetes within five years. Click title to continue reading...


  CASE ALERTS


C-Section Patient Death; Refusing Blood Transfusion on Religious Grounds; No Liability

At the beginning of the eighth month of pregnancy, a woman who adhered to the Jehovah’s Witness faith selected a hospital in which to give birth. According to testimony presented at the subsequent trial, adherents to the Jehovah’s Witness faith refuse to accept blood transfusions. The hospital the woman selected had a Bloodless Medicine Program with three clerical staff who were Jehovah’s Witnesses to engage patients who, for various reasons, refuse blood transfusions. Click title to continue reading...



Sexual Harassment Aggravating Pre-Existing Medical Conditions; Expert Required

A woman with fibromyalgia, depression, and radiculopathy was a patient at a doctor’s practice for approximately one year. The woman received treatment from a doctor at this practice for the psychological, emotional, and physical symptoms the woman was experiencing as a result of being the victim of sexual abuse and harassment. Click title to continue reading...



Brain Injury Disability Denial; Error to Ignore Treating Physicians

A 26-year-old woman with a history of bipolar disorder, anxiety, and panic attacks fell down a flight of stairs and suffered a brain hemorrhage. The fall caused a traumatic brain hemorrhage and brain contusion in the left hemisphere of the woman’s brain, which required that the woman be hospitalized. An EEG (electroencephalogram) performed to rule out epileptic activity showed mild brain damage. Click title to continue reading...


FEATURE


Checklist: Document Requests-CTE Negligence Litigation

As a special feature for our Premium subscribers we have included this feature containing a checklist for documents to gather and for discovery requests relevant to litigation involving repeat brain injury, resulting in chronic traumatic encephalopathy (CTE). In this illustrative situation, a student-athlete sustained multiple concussive head injuries while playing football. Click title to continue reading...